vs
Empire State Realty OP, L.P.（ESBA）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Empire State Realty OP, L.P.的季度营收约是Esperion Therapeutics, Inc.的1.2倍（$199.2M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 0.8%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 4.9%）
Empire State Realty OP, L.P. 是一家房地产运营合伙企业，核心业务为持有、管理及出租优质商业与零售物业，主要布局纽约大都会区，旗下拥有帝国大厦等标志性地标，服务企业租户、零售品牌及旅游相关业务板块。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
ESBA vs ESPR — 直观对比
营收规模更大
ESBA
是对方的1.2倍
$168.4M
营收增速更快
ESPR
高出142.9%
0.8%
两年增速更快
ESPR
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.2M | $168.4M |
| 净利润 | $32.2M | — |
| 毛利率 | — | — |
| 营业利润率 | 17.8% | 50.6% |
| 净利率 | 16.1% | — |
| 营收同比 | 0.8% | 143.7% |
| 净利润同比 | 71.2% | — |
| 每股收益（稀释后） | $0.11 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESBAESPR
| Q4 25 | $199.2M | $168.4M | ||
| Q3 25 | $197.7M | $87.3M | ||
| Q2 25 | $191.3M | $82.4M | ||
| Q1 25 | $180.1M | $65.0M | ||
| Q4 24 | $197.6M | $69.1M | ||
| Q3 24 | $199.6M | $51.6M | ||
| Q2 24 | $189.5M | $73.8M | ||
| Q1 24 | $181.2M | $137.7M |
净利润ESBAESPR
| Q4 25 | $32.2M | — | ||
| Q3 25 | $13.6M | $-31.3M | ||
| Q2 25 | $11.4M | $-12.7M | ||
| Q1 25 | $15.8M | $-40.5M | ||
| Q4 24 | $18.8M | — | ||
| Q3 24 | $22.8M | $-29.5M | ||
| Q2 24 | $28.6M | $-61.9M | ||
| Q1 24 | $10.2M | $61.0M |
营业利润率ESBAESPR
| Q4 25 | 17.8% | 50.6% | ||
| Q3 25 | 19.9% | -11.4% | ||
| Q2 25 | 18.4% | 8.6% | ||
| Q1 25 | 14.3% | -34.0% | ||
| Q4 24 | 21.7% | -6.4% | ||
| Q3 24 | 22.7% | -31.0% | ||
| Q2 24 | 20.8% | 3.5% | ||
| Q1 24 | 17.1% | 52.5% |
净利率ESBAESPR
| Q4 25 | 16.1% | — | ||
| Q3 25 | 6.9% | -35.9% | ||
| Q2 25 | 6.0% | -15.4% | ||
| Q1 25 | 8.8% | -62.2% | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 11.4% | -57.2% | ||
| Q2 24 | 15.1% | -83.9% | ||
| Q1 24 | 5.6% | 44.3% |
每股收益（稀释后）ESBAESPR
| Q4 25 | $0.11 | $0.32 | ||
| Q3 25 | $0.05 | $-0.16 | ||
| Q2 25 | $0.04 | $-0.06 | ||
| Q1 25 | $0.05 | $-0.21 | ||
| Q4 24 | $0.07 | $-0.14 | ||
| Q3 24 | $0.08 | $-0.15 | ||
| Q2 24 | $0.10 | $-0.33 | ||
| Q1 24 | $0.03 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $132.7M | $167.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $-302.0M |
| 总资产 | $4.5B | $465.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESBAESPR
| Q4 25 | $132.7M | $167.9M | ||
| Q3 25 | $154.1M | $92.4M | ||
| Q2 25 | $94.6M | $86.1M | ||
| Q1 25 | $187.8M | $114.6M | ||
| Q4 24 | $385.5M | $144.8M | ||
| Q3 24 | $421.9M | $144.7M | ||
| Q2 24 | $535.5M | $189.3M | ||
| Q1 24 | $333.6M | $226.6M |
股东权益ESBAESPR
| Q4 25 | — | $-302.0M | ||
| Q3 25 | — | $-451.4M | ||
| Q2 25 | — | $-433.5M | ||
| Q1 25 | — | $-426.2M | ||
| Q4 24 | — | $-388.7M | ||
| Q3 24 | — | $-370.2M | ||
| Q2 24 | — | $-344.2M | ||
| Q1 24 | — | $-294.3M |
总资产ESBAESPR
| Q4 25 | $4.5B | $465.9M | ||
| Q3 25 | $4.1B | $364.0M | ||
| Q2 25 | $4.1B | $347.1M | ||
| Q1 25 | $4.1B | $324.0M | ||
| Q4 24 | $4.5B | $343.8M | ||
| Q3 24 | $4.4B | $314.1M | ||
| Q2 24 | $4.4B | $352.3M | ||
| Q1 24 | $4.2B | $373.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $249.1M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $50.6M | — |
| 自由现金流率自由现金流/营收 | 25.4% | — |
| 资本支出强度资本支出/营收 | 99.6% | 0.0% |
| 现金转化率经营现金流/净利润 | 7.74× | — |
| 过去12个月自由现金流最近4个季度 | $109.3M | — |
8季度趋势，按日历期对齐
经营现金流ESBAESPR
| Q4 25 | $249.1M | $45.2M | ||
| Q3 25 | $105.3M | $-4.3M | ||
| Q2 25 | $26.7M | $-31.4M | ||
| Q1 25 | $83.1M | $-22.6M | ||
| Q4 24 | $260.9M | $-35.0M | ||
| Q3 24 | $102.8M | $-35.3M | ||
| Q2 24 | $37.1M | $-7.2M | ||
| Q1 24 | $70.9M | $53.8M |
自由现金流ESBAESPR
| Q4 25 | $50.6M | — | ||
| Q3 25 | $72.8M | — | ||
| Q2 25 | $-55.1M | — | ||
| Q1 25 | $41.1M | — | ||
| Q4 24 | $88.0M | — | ||
| Q3 24 | $-65.1M | $-35.5M | ||
| Q2 24 | $19.5M | $-7.3M | ||
| Q1 24 | $23.2M | $53.8M |
自由现金流率ESBAESPR
| Q4 25 | 25.4% | — | ||
| Q3 25 | 36.8% | — | ||
| Q2 25 | -28.8% | — | ||
| Q1 25 | 22.8% | — | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | -32.6% | -68.7% | ||
| Q2 24 | 10.3% | -9.9% | ||
| Q1 24 | 12.8% | 39.0% |
资本支出强度ESBAESPR
| Q4 25 | 99.6% | 0.0% | ||
| Q3 25 | 16.5% | 0.0% | ||
| Q2 25 | 42.8% | 0.0% | ||
| Q1 25 | 23.4% | 0.0% | ||
| Q4 24 | 87.5% | 0.0% | ||
| Q3 24 | 84.1% | 0.3% | ||
| Q2 24 | 9.3% | 0.1% | ||
| Q1 24 | 26.3% | 0.1% |
现金转化率ESBAESPR
| Q4 25 | 7.74× | — | ||
| Q3 25 | 7.72× | — | ||
| Q2 25 | 2.35× | — | ||
| Q1 25 | 5.27× | — | ||
| Q4 24 | 13.88× | — | ||
| Q3 24 | 4.51× | — | ||
| Q2 24 | 1.30× | — | ||
| Q1 24 | 6.94× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESBA
| Real Estate Segment | $163.8M | 82% |
| Observatory Segment | $35.2M | 18% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
